Celltex News
ChinaXiv Reports Clinical Remission of a Critically Ill COVID-19 Patient Treated by Human Umbilical Cord Mesenchymal Stem Cells
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
ChinaXiv has performed a recent study that has proven significant improvement of a critically ill COVID-19 patient that was treated with the transfer of human umbilical cord mesenchymal stem cells. Celltex is continuing to monitor and participate in this effective research.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
What Is Stem Cell Therapy?
Not all stem cell therapies are the same. If you’re looking into various stem cell therapy options, it’s important to understand which option may be best for your unique condition or health goals.
In this article, we explore two major types of stem cell therapy: same-day stem cell therapy and high-dose stem cell therapy. Read about how the two compare and when one option may be recommended over the other.
Read MorePhysician Panel on Stem Cell Therapy: Advanced Techniques in Regenerative Medicine
Celltex hosted a webinar with a panel of guest speakers that included esteemed, licensed physicians at Hospital Galenia in Cancun who have been working with Celltex Mexico for over a decade and who have extensive experience in regenerative medicine.
In this article, we’ll describe some of the key details from the panel discussion, specifically relating to the stem cell therapy process, its many clinical applications, and an in-depth look at several advanced regenerative medicine techniques.
Read More